Coverage with Evidence Development – Government-sponsored clinical trials
With the increasing evidence requirements from decision makers, it is essential to evaluate the different opportunities that exist to get reimbursement during the evidence development and government-sponsored clinical trials.
There are scenarios where companies can have large randomized clinical trials with complex outcomes and long follow-up paid by the government, while at the same time receive reimbursement.
Utilising these opportunities requires careful consideration of which country to approach and how to engage with the decision makers in this process.
In this session, we’ll cover:
- Introduction to Coverage with Evidence Development
- Routes to Coverage with Evidence Development and Government-sponsored clinical trials:
- Germany (137 e/h)
- France (PHRC, PRME, Innovation package, PECT/PECAN
- United Kingdom (NIHR)
- Recommended actions
Speakers:
- John West
- Mattias Kyhlstedt
- Michel Verhasselt
- Michael Weisser
Date and time : September 9th 16:00 CET